C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2011
12/08/2011	WO2011151298A1 Production of fatty acids by heterologous expression of gene clusters from myxobacteria
12/08/2011	WO2011150933A2 Energy saving brewing method
12/08/2011	WO2011150855A1 Micro-rna biomarkers and methods for diagnosis of early colorectal carcinoma and high-grade adenoma
12/08/2011	WO2011150841A1 Expression vector comprising human insulin gene and construction methods and applications thereof
12/08/2011	WO2011150833A1 Test tube, device comprising test tube and liquid treatment method by using same
12/08/2011	WO2011150745A1 Mycobacterium tuberculosis ag85ab chimeric gene vaccine, its preparation method and application
12/08/2011	WO2011150545A1 Snps associated with polycystic ovary syndrome, chips comprising the same and use thereof
12/08/2011	WO2011150470A1 Vitronectin:keratinocyte growth factor chimeras
12/08/2011	WO2011150453A1 Diagnostic, prognostic and therapeutic use of a long non-coding rna
12/08/2011	WO2011130627A3 Chimpanzee adenoviral vector-based filovirus vaccines
12/08/2011	WO2011121357A3 Transcription factor decoys
12/08/2011	WO2011103666A8 Modulation of cytokine-induced chronic inflammatory responses
12/08/2011	WO2011097509A3 Hypoxia-related gene signatures for cancer classification
12/08/2011	WO2011097456A3 Compositions and methods for enhanced parvovirus transduction
12/08/2011	WO2011097381A8 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations therof
12/08/2011	WO2011094683A9 Method of identifying myelodysplastic syndromes
12/08/2011	WO2011090272A3 OsMPT GENE MODIFYING PLANT ARCHITECTURE (PLANT SHAPE) AND INCREASING YIELD, AND USE THEREOF
12/08/2011	WO2011085066A3 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
12/08/2011	WO2011083500A3 Method of use of stabilized plant-derived growth factor in skin care
12/08/2011	WO2011071476A3 Compositions and methods for engineering cells
12/08/2011	WO2011062634A3 Monoclonal antibodies and diagnostic uses thereof
12/08/2011	WO2011053991A3 Vault complexes for cytokine delivery
12/08/2011	WO2011041350A3 Xenotropic mulv-related virus (xmrv) compositions and methods of use
12/08/2011	WO2010131193A8 Phosphodiesterase 9a as prostate cancer marker
12/08/2011	US20110302675 Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts
12/08/2011	US20110302674 Methods and Compositions for the Improvement of Plant Tolerance to Environmental Stresses
12/08/2011	US20110302672 Lowering saturated fatty acid content of plant seeds
12/08/2011	US20110302671 Embryo sac-specific genes
12/08/2011	US20110302670 Polynucleotides and methods for the improvement of plants
12/08/2011	US20110301930 Method for determining gene knockouts
12/08/2011	US20110301341 Modified organs and cells for xenotransplantation
12/08/2011	US20110301339 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301338 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301337 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301331 Stabilized polypeptide compositions
12/08/2011	US20110301329 Process for the Purification of Recombinant Albumin
12/08/2011	US20110301230 Gene carrier
12/08/2011	US20110301229 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/08/2011	US20110301228 Gene therapy vector for treatment of steroid glaucoma
12/08/2011	US20110301226 Compositions and methods for treating hepatic neoplasia
12/08/2011	US20110301224 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/08/2011	US20110301223 Compositions and methods for insecticidal control of stinkbugs
12/08/2011	US20110301220 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
12/08/2011	US20110301219 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
12/08/2011	US20110301218 MODIFIED snRNAs FOR USE IN THERAPY
12/08/2011	US20110301093 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
12/08/2011	US20110301092 The use of a non-glycanated polypeptide for treating a cancer
12/08/2011	US20110301064 Signal sequence-independent pix phage display
12/08/2011	US20110301048 Diagnosis and prognosis of breast cancer patients
12/08/2011	US20110300633 Novel promoter for use in transformation of algae
12/08/2011	US20110300632 Method of directing the evolution of an organism
12/08/2011	US20110300631 Method for suppressing cell growth
12/08/2011	US20110300629 TRAIL trimers, methods and uses therefor
12/08/2011	US20110300605 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
12/08/2011	US20110300604 Recombinant influenza vectors with tandem transcription units
12/08/2011	US20110300600 Methods and compositions for delivering polynucleotides
12/08/2011	US20110300583 In vitro recombination methods using 5' exonuclease
12/08/2011	US20110300582 Corynebacteria Strain Having Enhanced 5'-Xanthosine Monophosphate Productivity and a Method of Producing 5'-Xanthosine Monophosphate Using the Same
12/08/2011	US20110300580 Selection of host cells expressing protein at high levels
12/08/2011	US20110300578 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110300577 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110300576 T7 expression system
12/08/2011	US20110300557 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
12/08/2011	US20110300538 Bifidobacteria crispr sequences
12/08/2011	US20110300537 Methods of detecting sequence differences
12/08/2011	US20110300533 Yeast Screens for Treatment of Human Disease
12/08/2011	US20110300183 Method of preparing adenosine-resistant anti-tumor t lymphocytes for adoptive immunotherapy
12/08/2011	US20110300182 Nucleic acid drug for treatment of allergic disease
12/08/2011	US20110300180 plant-derived vaccines against respiratory syncytial virus
12/08/2011	US20110300176 Microorganisms for therapy
12/08/2011	US20110300164 Immunostimulatory dna:rna oligonucleotides
12/08/2011	US20110300158 Anti-serum albumin binding variants
12/08/2011	US20110300156 Human antibodies against tissue factor
12/08/2011	US20110300139 Generation, expression and characterization of the humanized k33n monoclonal antibody
12/08/2011	US20110300138 Human anti tshr antibodies
12/08/2011	US20110300125 Compositions and methods for combined therapy of disease
12/08/2011	US20110300115 Use of inductor agents gse24.2 for producing pharmaceutical compositions for treating illnesses relating to cellular senescence
12/08/2011	US20110300113 Death Receptor CD95 Controls Neurogenesis of Adult Neural Stem Cells in Vivo and in Vitro
12/08/2011	US20110300099 Multi-level specific targeting of cancer cells
12/08/2011	US20110300077 Human Anti-Alpha-Synuclein Antibodies
12/08/2011	DE102010022937A1 Zellspezifisch aktivierbare biologisch wirksame Moleküle auf Grundlage von siRNA, Verfahren zu deren Aktivierung sowie Applikationskit zur Verabreichung Cell-specific activatable biologically active molecules on the basis of siRNA, methods for their activation and application kit for administering
12/08/2011	DE102008013715B4 Verfahren zur DNA-Analyse A method of DNA analysis
12/08/2011	DE102004010928B4 Protein zur Bindung prokaryonter DNA sowie Verfahren zur Trennung und Anreicherung prokaryonter DNA Protein binding to prokaryotic DNA as well as methods for the separation and enrichment of prokaryotic DNA
12/08/2011	CA2805270A1 Treatment of inflammatory disorders
12/08/2011	CA2802627A1 Recombinant production of steviol glycosides
12/08/2011	CA2801799A1 Filamentous fungal host strains and dna constructs, and methods of use thereof
12/08/2011	CA2801599A1 Method for improved protein production in filamentous fungi
12/08/2011	CA2801577A1 Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose
12/08/2011	CA2801575A1 Methods for improving inflammatory bowel disease diagnosis
12/08/2011	CA2801535A1 Composition and method for inner ear sensory hair cell regeneration or replacement
12/08/2011	CA2801346A1 Ideotypically modulated pharmacoeffectors for selective cell treatment
12/08/2011	CA2801342A1 Regulation of metabolism by mir-378
12/08/2011	CA2801268A1 Novel method for generation of rna virus
12/08/2011	CA2801240A1 Vitronectin:keratinocyte growth factor chimeras
12/08/2011	CA2801223A1 Fusion protein having factor vii activity
12/08/2011	CA2801142A1 Energy saving brewing method
12/08/2011	CA2801066A1 Compositions and methods directed to treating liver fibrosis
12/08/2011	CA2800863A1 Method for producing tumor cell
12/08/2011	CA2800824A1 Novel modified live-attenuated vaccines (mlv) and subunit vaccines created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv)
12/08/2011	CA2800401A1 Biodegradable lipids for the delivery of active agents

1 ... 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 ... 4023